Table 3.

Acquired factor deficiencies associated with bleeding

DeficiencyProlonged aPTT and PTProlonged aPTT, nl PTProlonged PT, nl aPTTNormal aPTT and PT 
FibrinogenFIIFV45 FX46 FVIIIFIXFXIFVIIFXIII47-49 
Predisposing
factors 
DIC
Liver disease
Trauma
MGUS, MM50 
Asparaginase51  
Liver disease
Sepsis
Vitamin K deficiency 
Inhibitor
Topical bovine thrombin
Antibiotics 
Amyloidosis
Liver disease
Vitamin K deficiency 
Inhibitor
DIC
AVWS with reduced FVIII 
Inhibitor
DIC
Liver disease
Vitamin K deficiency 
Inhibitor
DIC
Liver disease 
Liver disease
Sepsis
Vitamin K deficiency
Vitamin K antagonist 
Inhibitor
Liver disease
Post op
Cardiovascular bypass
Inflammatory bowel disease 
DeficiencyProlonged aPTT and PTProlonged aPTT, nl PTProlonged PT, nl aPTTNormal aPTT and PT 
FibrinogenFIIFV45 FX46 FVIIIFIXFXIFVIIFXIII47-49 
Predisposing
factors 
DIC
Liver disease
Trauma
MGUS, MM50 
Asparaginase51  
Liver disease
Sepsis
Vitamin K deficiency 
Inhibitor
Topical bovine thrombin
Antibiotics 
Amyloidosis
Liver disease
Vitamin K deficiency 
Inhibitor
DIC
AVWS with reduced FVIII 
Inhibitor
DIC
Liver disease
Vitamin K deficiency 
Inhibitor
DIC
Liver disease 
Liver disease
Sepsis
Vitamin K deficiency
Vitamin K antagonist 
Inhibitor
Liver disease
Post op
Cardiovascular bypass
Inflammatory bowel disease 

DIC, disseminated intravascular coagulation; MGUS, monoclonal gammopathy of unknown significance; nl, normal; PT, prothrombin time.

Acquired platelet dysfunction from medications/exposures should also be considered when a patient presents with new bleeding symptoms with a normal aPTT and PT.

or Create an Account

Close Modal
Close Modal